Oyama Takashi | Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital
スポンサーリンク
概要
- OYAMA Takashiの詳細を見る
- 同名の論文著者
- Department Of Hematology And Oncology Nagoya Daini Red Cross Hospitalの論文著者
関連著者
-
OYAMA Takashi
Department of Medical Oncology, Aichi Cancer Center
-
Yamamoto Kazuhito
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
Nakamura Shigeo
Department Of Pathology Nagoya University School Of Medicine
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
著作論文
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Study of π^+π^- Pair Production in a Two-Photon Process at TRISTAN : VENUS Collaboration
- New Limits on Neutral Scalar Bosons
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- SQUAMOUS CELL PAPILLOMA OF THE ESOPHAGUS : CLINICOPATHOLOGICAL STUDY OF 24 CASES
- Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy